Exam II Study Materials for DPT VI with Focus on Generalized Anxiety Disorder and Pharmacological Interventions

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/131

encourage image

There's no tags or description

Looks like no tags are added yet.

132 Terms

1
New cards

DSM 5 Diagnosis: GAD

at least 6 months of symptoms, difficulty controlling the worry

presence of at least 3 symptoms: feeling keyed up or on edge, becoming easily fatigued, mind going blank, irritability, muscle tension, sleep disturbance

2
New cards

Clinical Presentation of GAD

irritability

restlessness

excessive worry

racing thoughts

sweating/blushing

tachycardia, arrhythmias

chest pain, muscle tightness, N/V/D

decreased social and occupational function

3
New cards

GAD-7 5-9

mild

4
New cards

GAD-7 10-14

moderate

5
New cards

GAD-7 > 15

severe

6
New cards

DSM5 Panic Disorder

recurrent unexpected panic attacks with at least 1 of the attacks being followed by a month or longer of at least 1 of the following:

constant concern about having another one

being anxious about implications of attack

maladaptive change in behavior designed to avoid it

7
New cards

Panic Attacks

spontaneous, unexpected, transient period of intense fear (lasts 20-30 minutes)

at least 4 of the following symptoms:

palpitations, diaphoresis, trembling, SOB, choking feeling, chest pain, paresthesia, chills/hot flashes, fear of dying, derealization, dizziness/faintness, fear of going crazy

8
New cards

Panic Attack vs Disorder

attack= single event

disorder = several attacks + persistent fear ( > 1 mo)

9
New cards

Risk factors for social anxiety disorder

over-protection from parental control, early childhood anxiety disorders, life stressors, psychiatric comorbidities, adverse life experiences

10
New cards

DSM-5 SAD

significant anxiety or fear about at least one social situation where the individual is exposed to possible scrutiny by others

fears display anxiety symptoms or act in a way that will be negatively assessed

anxiety, fear, avoidance is persistent with duration of 6 months or longer

11
New cards

Clinical Presentation of SAD

fears: embarrassment, humiliation, scrutinized by others

feared situations: public speaking, eating or drinking in front of others, interacting with authority figures

physical: blushing, butterflies, diarrhea, sweating, tachy

12
New cards

Clinical Presentation of PTSD

intrusion: feeling that traumatic event is recurring, recurrent, disturbing dreams of event

avoidance: avoidance of thoughts feelings or conversations and reminders

reactivity: decreased concentration, easily startled, reckless behavior

mood/cognition: inability to recall important aspects of trauma, negative expectations, distorted cognitions

13
New cards

Short Term Goals of anxiety disorders

reduce symptoms frequency and severity

improve function

14
New cards

Long Term Goals of anxiety disorders

symptom remission

no functional impairment

improved quality of life

15
New cards

What is first line for anxiety disorders?

SSRI/SNRIs

16
New cards

Counseling Points for SSRIs and SNRIs

initial symptom improvement takes at least 2-4 weeks, may take up to 8 weeks

adequate trial: 12 weeks

titrate to optimal dose

avoid abrupt discontinuation

17
New cards

What anxiety disorders does pregabalin have efficacy for?

generalized and social anxiety disorder

18
New cards

Onset of effect of pregabalin

< 1 week

works a lot faster, and can be considered 1st line option for GAD

19
New cards

Adverse effects of Pregabalin

edema

sedation

vision changes (dose-dependent)

weight gain

20
New cards

Starting Dose of Pregabalin

150 mg daily in 3 divided doses (50 mg TID)

take after a meal to increase bioavailability

target dose: 150-600 mg/day; increase by 150 mg/day each week

21
New cards

Precautions and warnings for Pregabalin

risk of respiratory depression with opioids and other medications

22
New cards

At what CrCl should you decrease dose of pregabalin?

< 60 mL/min

23
New cards

Drug interactions of pregabalin

opioids, alcohol, CNS depressants

24
New cards

What is buspirone FDA approved for?

generalized anxiety disorder

25
New cards

Place in therapy for Buspirone in GAD

effective 2nd line monotherapy or augmentation in GAD

26
New cards

Initial dosing for buspirone

5 mg BID/TID

titrate 5 mg every 2-3 days

typical dose: 15 mg BID

27
New cards

When is busiprone NOT recommended for use?

those with hepatic or renal impairment

28
New cards

Adverse effects of buspirone

generally well tolerated

nausea/dizziness/headache

29
New cards

Drug Interactions of Buspirone

CYP3A4 inhibitors and inducers

30
New cards

Warnings/Precautions of Buspirone

may cause akathisia

31
New cards

Counseling Points of Buspirone

delayed onset of action, similar to SSRIs/SNRIs

not a PRN medication - needs to be taken consistently for best effect

32
New cards

What is hydroxyzine approved for?

generalized anxiety disorder

33
New cards

What is hydroxyzine usually used for?

often "as needed" due to onset of action (effects seen within 30 minutes)

considered 2nd line therapy in GAD, could also be useful for insomnia with anxiety

34
New cards

Dosing for Hydroxyzine

25 mg BID scheduled OR prn

35
New cards

Dosing Adjustments for Hydroxyzine

ELDERY, due to adverse effects must use lower doses

hepatic impairment: expand to every 24 hours

36
New cards

Warning/Precautions for hydroxyzine

BPH

dementia

constipation

narrow angle glaucoma

CNS depression

elderly

37
New cards

Adverse effects of Hydroxyzine

anticholinergic (constipation, blurred vision, dry mouth), sedation

38
New cards

Drug Interactions of Hydroxyzine

alcohol, BZDs, opioids, TCAs, benztropine, other antihistamines

39
New cards

What TCAs are used in anxiety disorders?

imipramine, clomipramine, amitriptyline

40
New cards

Place in therapy for TCAs in anxiety disorders

useful when SSRI/SNRIs are ineffective or unable to be tolerated by patients

41
New cards

Why are TCAs limited in use in anxiety disorders?

poor tolerability and risk of serious adverse reactions

42
New cards

Which MAOI is most commonly used in anxiety disorders?

phenelzine

43
New cards

Place in therapy for phenelzine

at least 3rd line agent

only in patients refractory to standard treatment and augmentation

literally last line

44
New cards

Can SGAs be used as monotherapy in anxiety disorders?

NEVER EVER EVER

45
New cards

What SGAs are most effective/studied in anxiety disorders?

olanzapine, risperidone and quetiapine

46
New cards

Place in therapy for SGAs in anxiety disorder

viewed as alternative and or adjunct therapy in TREATMENT RESISTANT anxiety disorders

47
New cards

Which SGA works the best in GAD and PTSD?

quetiapine

48
New cards

Which SGA works best in SAD

olanzapine

49
New cards

What two drugs can be used as add-on therapy for sleep disturbances (nightmares) in PTSD?

prazosin and clonidine

50
New cards

Prazosin

alpha 1 agonist, used for sleep disturbances in ptsd

dose at bedtime: 1-16 mg/day

51
New cards

Clonidine

alpha 2 agonist, used for sleep disturbances in ptsd

dose variable: 0.2-0.6 mg daily, divided doses

52
New cards

Side effects of prazosin

orthostatic hypotension, dizziness, palpitations, first dose syncope

53
New cards

Side effects of clonidine

hypotension, dry mouth, dizziness, syncope, rebound hypertension

54
New cards

Benzodiazepines

generally utilized as add-on or second line (typically not used as monotherapy)

can be useful in acute phase management of anxiety (2-3 weeks until full effect of antidepressants)

55
New cards

Are benzodiazepines useful in ptsd?

nope

56
New cards

Adverse Effects of Benzodiazepines

sedation, psychomotor impairment, impaired cognition, vision changes, hypotension, dry mouth, amnesia, coma, respiratory depression

57
New cards

Patients who take BZDs long term...

higher risk for memory and concentration problems, daytime fatigue, falls and fractures, increased risk of having a moto vehicle accident while driving

58
New cards

What are some additional concerns with benzodiazepines?

misuse, addiction and overdose

59
New cards

What two benzodiazepines are preferred in older adults?

lorazepam and oxazepam

60
New cards

Are all benzodiazepines dosed the same?

no! there is a chart that you can base doses off of lorazepam

61
New cards

Which benzodiazepines are short acting?

alprazolam

lorazepam

oxazepam

62
New cards

Which benzodiazepines are long acting?

clonazepam

chlordiazepoxide

diazepam

63
New cards

PK/PD result in elderly with BZDs

increases drug exposure

64
New cards

Common Symptoms of Benzodiazepine Withdrawal

anxiety, insomnia, restlessness, muscle tension, irritability

SEIZURES

65
New cards

Seizures in BZD withdrawal

usually occurs with short half life agents and occur within 3 days of abrupt discontinuation

can occur up to 1 week or later after abrupt discontinuation in longer half life agents

66
New cards

Who is at risk to experiences seizures with BZDs withdrawal?

higher doses

longer duration of use

combination of other agents that lower seizure threshold

67
New cards

Discontinuation Principle of BZD

10-25% reduction every 1-2 weeks UNTIL 50% of dose is reached

pause and stabilize at 50% of dose

then once stabilized, resume but utilize lower % reduction and space out taper

68
New cards

SSRI/SNRIs are useful with co-morbid

MDD

69
New cards

Pregabalin is useful with co-morbid

chronic pain

70
New cards

TCA may be useful with co-morbid

insomnia

71
New cards

DSM-5 Diagnosis for OUD and AUD

decline in functioning: failure to fulfill major role, important social, occupational or recreational activities are reduced or given up

loss of control: taking larger amounts or for a longer time period, persistent desire, trying to obtain, craving

continued use despite negative consequences

72
New cards

OUD (opioid use disorder) AND AUD (alcohol use disorder)

problematic pattern of substance use with clinically significant distress or impairment with at least 2 of the following within a 12 month period

73
New cards

Short Term goals of treatment for OUD

eliminate withdrawal and cravings

reduce immediate risk associated with opioid misuse

74
New cards

Long Term Goals of Treatment for OUD

increase social functioning

remission of opioid addiction

75
New cards

What medications can be used for OUD?

methadone

buprenorphine/naloxone (suboxone)

naltrexone

76
New cards

Onset of Action of Methadone

within hours

but a FULL opioid agonist (so could have more withdrawal)

77
New cards

What is the restriction of methadone?

controlled substance that has to be obtained from a clinic

must be prescribed, dispensed, and administered

78
New cards

Patient Considerations for Methadone

long half life (once daily)

consider for pregnant patients

good for those who need structured environment

no withdrawal required to start treatment

79
New cards

What is required to be offered for every opioid use medication?

naloxone

80
New cards

Safety Monitoring for Methadone

RR, HR, BP, QTc, urine drug screens

81
New cards

Counseling Points for methadone

avoid alcohol and BZD

if admitted, dose and adherence needs to be confirmed by OTP

82
New cards

Patient Considerations for Suboxone

can be dispensed at local pharmacy

long half life

multiple formulations available

standard induction requires mild-mod opioid withdrawal

83
New cards

Counseling Points for Suboxone

avoid acidic drinks and nicotine prior to dose

avoid alcohol and BZDs

CAN split tablet or film

HOLD tablet or film under tongue for several minutes until it dissolves

84
New cards

Microinduction Theory with Suboxone

gradual increase of buprenorphine dose will incrementally displace full agonist but not enough to precipitate withdrawal

once target dose achieved (16 mg/day), full agonist can be displaced and stopped

85
New cards

Patient Considerations for Naltrexone

non-opioid agonist option (for those wanting to avoid opioids in treatment)

long acting INJECTABLE

no abuse potential

approved for OUD and AUD

86
New cards

Warnings and Precautions for Naltrexone

acute hepatitis

severe hepatic impairment

depression and suicidal thoughts

DO NOT USE IN PREGNANT PATIENTS

caution in decompensated cirrhosis and those with renal impairment

87
New cards

Initiation of Naltrexone

MUST be off opioids for a minimum of 7-10 days

onset: 24 hours (IM)

88
New cards

Counseling Points for Naltrexone

opioid free for > 7-10 days

alert all providers that you are on this

avoid opioids for pain management

injection is every 28 days

ensure have emergency card

must be observed taking this medication for OUD

89
New cards

Does naltrexone reduce withdrawal symptoms?

no

90
New cards

Which MOUD has mortality benefits?

buprenorphine and methadone

91
New cards

Goals of Treatment for Maintenance of AUD

decrease number of days drinking, heavy drinking, and drinks per day

minimize physical, psychological, financial, and social harm

92
New cards

What are the three drugs that can be used for AUD?

acamprosate, disulfiram, naltrexone

93
New cards

Acamprosate

TID dosing

oral tablet

adverse events: diarrhea, insomnia, anxiety, depression, weakness

94
New cards

Contraindications for Acamprosate

CrCl < 30 mL/min

95
New cards

Warnings and Precautions for Acamprosate

suicidal ideation and depression, alcohol withdrawal (DOES NOT TREAT), renal impairment

96
New cards

Disulfiram

250 mg daily, oral tablet

97
New cards

Contraindications for Disulfiram

severe myocardial disease

use of alcohol products within 14 days after discontinuing

psychosis

recent or current use of metro

98
New cards

How long does disulfiram effect last after last dose?

1-2 weeks

99
New cards

When should you NOT initiate disulfiram?

at least 12-24 hours after ingesting alcohol

BAL of 0 required

100
New cards

Adverse effects of disulifram

disulifram reaction: warmness and flushing of skin, increased HR, palpitations, decreased BP